| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.040 | None | 1.000 | 4 | 2 | 2011 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily C member 1 | 0.566 | 0.769 | 1.3E-02 |
|
disease | 0.240 | None | 0.750 | 4 | 2 | 2008 | 2013 | ||||||||
|
FERM domain containing 3 | 0.760 | 0.269 | 0.27 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2009 | 2016 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.030 | None | 0.667 | 3 | 2 | 2007 | 2018 | ||||||||
|
xylosyltransferase 1 | 0.581 | 0.731 | 0.92 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2005 | 2006 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2001 | 2004 | ||||||||
|
carboxypeptidase B2 | 0.536 | 0.846 | 2.7E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2012 | 2012 | ||||||||
|
NLR family pyrin domain containing 1 | 0.502 | 0.769 | 5.0E-19 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
interleukin 19 | 0.558 | 0.769 | 4.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
LDL receptor related protein 5 | 0.485 | 0.846 | 0.51 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
lymphotoxin alpha | 0.434 | 0.885 | 0.20 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 1997 | 1997 | ||||||||
|
proteasome 26S subunit, non-ATPase 9 | 0.435 | 0.846 | 4.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
LARGE xylosyl- and glucuronyltransferase 1 | 0.526 | 0.654 | 0.99 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.600 | None | 0.990 | 99 | 1 | 1996 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.976 | 42 | 1 | 1999 | 2019 | ||||||||
|
aldo-keto reductase family 1 member B | 0.491 | 0.885 | 2.0E-05 |
|
disease | 0.100 | None | 0.971 | 34 | 1 | 1997 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 0.969 | 32 | 1 | 2000 | 2020 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.300 | None | 0.867 | 30 | 1 | 1996 | 2019 | ||||||||
|
carnosine dipeptidase 1 | 0.656 | 0.538 | 1.2E-09 |
|
disease | 0.400 | None | 0.929 | 28 | 1 | 2005 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 1.000 | 22 | 1 | 2001 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.300 | None | 1.000 | 16 | 1 | 2008 | 2020 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 2010 | 2019 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.498 | 0.808 | 5.0E-08 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2002 | 2015 | ||||||||
|
uromodulin | 0.520 | 0.846 | 3.1E-17 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2011 | 2019 | ||||||||
|
apolipoprotein L1 | 0.547 | 0.615 | 5.1E-06 |
|
disease | 0.170 | None | 1.000 | 8 | 1 | 2011 | 2019 |